Christoph Josef Auernhammer

10PUBLICATIONS
31CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer geneticsPredictive and prognostic markersOncology and carcinogenesis not elsewhere classified
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Jan 10, 2026
Personalized Drug Screening and Risk Assessment in Patient-Derived Gastroenteropancreatic Neuroendocrine Neoplasms.

Christoph J Auernhammer, Katharina Wang, Umberto Maccio

|May 14, 2025
Comparison of the Hematotoxicity of PRRT with Lutathera® and Locally Manufactured 177Lu-HA-DOTATATE in Patients with Neuroendocrine Tumors and the Impact of Different Application Intervals.

Markus Hofmann, Sophie C Kunte, Marcus Unterrainer

|Jan 02, 2025
Long-Term Persistence of Glycemic Dysregulation in Patients With a History of Pheochromocytoma/Paraganglioma.

Alessa Fischer, Hanna Remde, Christina Pamporaki

|Nov 14, 2023
PD-L1 and HIF-2α Upregulation in Head and Neck Paragangliomas after Embolization.

Alessa Fischer, Umberto Maccio, Katharina Wang

|Oct 27, 2022
Treatment Assessment of pNET and NELM after Everolimus by Quantitative MRI Parameters.

Maria Ingenerf, Sophia Kiesl, Michael Winkelmann

|Aug 27, 2021
Molecular Imaging with 18F-FDG PET/CT and 99mTc-MIBI SPECT/CT in Osteitis Fibrosa Cystica Generalisata.

Adrien Holzgreve, Matthias P Fabritius, Thomas Knösel

Pageof 2

Frequent Collaborators

4 joint publications

Johannes Rübenthaler

3 joint publications

Matthias Philipp Fabritius

3 joint publications

Katharina Wang

2 joint publications

Ralph Fritsch